BioMedPartners and BB Pureos Bioventures have co-led a CHF 12.5m series-A for biotechnology company Alentis Therapeutics.
Investment was reportedly equally split between equity and debt
Pfaudler's listed subsidiary, GMM Pfaudler, acquires an 80% stake in the business
Lawyers were originally part of a team hired from Kirkland & Ellis's London office in April 2016
Space-tech startup has so far raised $152m since being founded in 2015